1 Study Coverage 1.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Introduction 1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Outlook 2017 VS 2022 VS 2028 1.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size for the Year 2017-2028 1.2.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size for the Year 2017-2028 1.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Dynamics 1.4.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Industry Trends 1.4.2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Drivers 1.4.3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Challenges 1.4.4 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers by Type 2.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Segment by Type 2.1.1 Hemostats 2.1.2 Internal Tissue Sealants 2.1.3 Adhesion Barriers 2.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2017, 2022 & 2028) 2.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2017-2028) 2.4 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2017, 2022 & 2028) 2.5 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2017-2028) 3 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers by Application 3.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Segment by Application 3.1.1 Hospitals 3.1.2 Clinics & Trauma Centers 3.1.3 Ambulatory Surgical Centers 3.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2017, 2022 & 2028) 3.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2017-2028) 3.4 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2017, 2022 & 2028) 3.5 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2017-2028) 4 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Competitor Landscape by Company 4.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Company 4.1.1 Top Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Companies Ranked by Revenue (2021) 4.1.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Player (2017-2022) 4.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Concentration Ratio (CR) 4.2.1 Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers in 2021 4.2.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Headquarters, Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Type 4.3.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Headquarters and Area Served 4.3.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Companies Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Company 4.5.1 Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players in United States, Ranked by Revenue (2021) 4.5.2 United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Players (2020, 2021 & 2022) 5 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region 5.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2017-2028) 5.2.1 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region: 2017-2022 5.2.2 Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth 2017-2028 6.1.2 North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth 2017-2028 6.3.2 Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth 2017-2028 6.4.2 Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Baxter 7.1.1 Baxter Company Details 7.1.2 Baxter Business Overview 7.1.3 Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.1.4 Baxter Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.1.5 Baxter Recent Development 7.2 Ethicon 7.2.1 Ethicon Company Details 7.2.2 Ethicon Business Overview 7.2.3 Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.2.4 Ethicon Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.2.5 Ethicon Recent Development 7.3 B. Braun Melsungen 7.3.1 B. Braun Melsungen Company Details 7.3.2 B. Braun Melsungen Business Overview 7.3.3 B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.3.4 B. Braun Melsungen Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.3.5 B. Braun Melsungen Recent Development 7.4 Sanofi 7.4.1 Sanofi Company Details 7.4.2 Sanofi Business Overview 7.4.3 Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.4.4 Sanofi Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.4.5 Sanofi Recent Development 7.5 C. R. Bard 7.5.1 C. R. Bard Company Details 7.5.2 C. R. Bard Business Overview 7.5.3 C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.5.4 C. R. Bard Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.5.5 C. R. Bard Recent Development 7.6 Integra Lifesciences 7.6.1 Integra Lifesciences Company Details 7.6.2 Integra Lifesciences Business Overview 7.6.3 Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.6.4 Integra Lifesciences Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.6.5 Integra Lifesciences Recent Development 7.7 Cryolife 7.7.1 Cryolife Company Details 7.7.2 Cryolife Business Overview 7.7.3 Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.7.4 Cryolife Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.7.5 Cryolife Recent Development 7.8 Tissuemed 7.8.1 Tissuemed Company Details 7.8.2 Tissuemed Business Overview 7.8.3 Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.8.4 Tissuemed Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.8.5 Tissuemed Recent Development 7.9 Cohera Medical 7.9.1 Cohera Medical Company Details 7.9.2 Cohera Medical Business Overview 7.9.3 Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.9.4 Cohera Medical Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.9.5 Cohera Medical Recent Development 7.10 Pfizer 7.10.1 Pfizer Company Details 7.10.2 Pfizer Business Overview 7.10.3 Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Introduction 7.10.4 Pfizer Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) 7.10.5 Pfizer Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Trends Table 3. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Drivers Table 4. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Challenges Table 5. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Restraints Table 6. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Player, 2017-2022 Table 13. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers as of 2021) Table 15. Top Players of Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Players in United States Market, Ranking by Revenue (2021) Table 20. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Baxter Company Details Table 31. Baxter Business Overview Table 32. Baxter Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 33. Baxter Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 34. Baxter Recent Development Table 35. Ethicon Company Details Table 36. Ethicon Business Overview Table 37. Ethicon Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 38. Ethicon Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 39. Ethicon Recent Development Table 40. B. Braun Melsungen Company Details Table 41. B. Braun Melsungen Business Overview Table 42. B. Braun Melsungen Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 43. B. Braun Melsungen Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 44. B. Braun Melsungen Recent Development Table 45. Sanofi Company Details Table 46. Sanofi Business Overview Table 47. Sanofi Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 48. Sanofi Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 49. Sanofi Recent Development Table 50. C. R. Bard Company Details Table 51. C. R. Bard Business Overview Table 52. C. R. Bard Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 53. C. R. Bard Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 54. C. R. Bard Recent Development Table 55. Integra Lifesciences Company Details Table 56. Integra Lifesciences Business Overview Table 57. Integra Lifesciences Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 58. Integra Lifesciences Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 59. Integra Lifesciences Recent Development Table 60. Cryolife Company Details Table 61. Cryolife Business Overview Table 62. Cryolife Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 63. Cryolife Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 64. Cryolife Recent Development Table 65. Tissuemed Company Details Table 66. Tissuemed Business Overview Table 67. Tissuemed Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 68. Tissuemed Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 69. Tissuemed Recent Development Table 70. Cohera Medical Company Details Table 71. Cohera Medical Business Overview Table 72. Cohera Medical Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 73. Cohera Medical Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 74. Cohera Medical Recent Development Table 75. Pfizer Company Details Table 76. Pfizer Business Overview Table 77. Pfizer Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Table 78. Pfizer Revenue in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) & (US$ Million) Table 79. Pfizer Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Product Picture Figure 2. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size 2017-2028 (US$ Million) Figure 4. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size 2017-2028 (US$ Million) Figure 6. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share in Global 2017-2028 Figure 7. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Report Years Considered Figure 8. Product Picture of Hemostats Figure 9. Product Picture of Internal Tissue Sealants Figure 10. Product Picture of Adhesion Barriers Figure 11. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type in 2022 & 2028 Figure 12. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2017-2028) & (US$ Million) Figure 13. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type (2017-2028) Figure 14. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type in 2022 & 2028 Figure 15. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Type (2017-2028) & (US$ Million) Figure 16. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Type (2017-2028) Figure 17. Product Picture of Hospitals Figure 18. Product Picture of Clinics & Trauma Centers Figure 19. Product Picture of Ambulatory Surgical Centers Figure 20. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application in 2022 & 2028 Figure 21. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2017-2028) & (US$ Million) Figure 22. Global Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application (2017-2028) Figure 23. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application in 2022 & 2028 Figure 24. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size by Application (2017-2028) & (US$ Million) Figure 25. United States Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Share by Application (2017-2028) Figure 26. North America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate 2017-2028 (US$ Million) Figure 27. U.S. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Canada Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. Europe Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate 2017-2028 (US$ Million) Figure 30. Germany Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. France Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. U.K. Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Italy Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Russia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Asia-Pacific Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate 2017-2028 (US$ Million) Figure 36. China Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Japan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. South Korea Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. India Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Australia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Taiwan Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Indonesia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Thailand Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Malaysia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Philippines Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Latin America Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate 2017-2028 (US$ Million) Figure 47. Mexico Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Brazil Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Argentina Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Middle East & Africa Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate 2017-2028 (US$ Million) Figure 51. Turkey Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Saudi Arabia Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. UAE Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Baxter Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 55. Ethicon Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 56. B. Braun Melsungen Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 57. Sanofi Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 58. C. R. Bard Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 59. Integra Lifesciences Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 60. Cryolife Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 61. Tissuemed Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 62. Cohera Medical Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 63. Pfizer Revenue Growth Rate in Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Baxter Ethicon B. Braun Melsungen Sanofi C. R. Bard Integra Lifesciences Cryolife Tissuemed Cohera Medical Pfizer